地中海贫血长期输血患者接受RhD、C、E和K匹配输血后的Rh同种免疫
这项回顾性研究纳入40例长期输血的地中海贫血患者,平均接受174单位经血清学预防性RhD、C、E和K匹配的红细胞。
要点
- 32.5%患者仍产生同种抗体,0.26抗体/100单位输血。
- 72.2%抗体针对Rh系统,无法用患者RH基因型或供者表型解释。
- 将Rh匹配扩展至c和e可能减少Rh同种免疫。
核心结论
- 接受RhD、C、E和K匹配输血的地中海贫血患者仍发生Rh同种免疫,部分无法用患者RH基因型或供者血清学表型解释。
- 将Rh匹配扩展至c和e可能实现更佳匹配并进一步减少Rh同种免疫。
研究设计与样本
- 回顾性研究,纳入40例长期输血的地中海贫血患者(亚洲、白人、黑人、印度、中东裔)。
- 患者平均接受174单位经血清学预防性RhD、C、E和K匹配的红细胞。
主要发现
- 13种抗体(72.2%)针对Rh系统:5种抗-D、4种抗-C、2种抗-E、1种抗-e、1种抗-V,尽管供者表型确认未向缺乏相应抗原的患者输注D、C或E抗原。
- 10/40例患者存在 altered RH genotype,但Rh抗体与变异RH基因型无关联。
- 在无法解释的抗Rh检出前3次输血中,已知高频RH变异的黑人供者提供了63%的输血单位。
临床怎么用
- 对于长期输血的地中海贫血患者,即使已实施RhD、C、E和K匹配,仍需警惕Rh同种免疫。
- 考虑将Rh匹配扩展至c和e抗原以减少同种免疫风险。
- 探索供者RH基因型在同种免疫中的作用可能有助于优化匹配策略。
局限性
- 回顾性研究,样本量较小(40例患者)。
- 未明确报告供者RH基因型与同种免疫的直接关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronically transfused patients with thalassemia are at risk for red cell alloimmunization. No studies have specifically examined alloimmunization after implementation of prophylactic Rh (D, C, E) and K matched red cells in a racially diverse population of thalassemia patients and donors. This retrospective study examined Rh antibodies among 40 chronically transfused patients (Asian, White, Black, Indian, Middle Eastern) with thalassemia receiving a mean of 174 serologic prophylactic RhD, C, E, and K matched red cell units. We examined the patients' RH genotype, as well as donor race and Rh phenotypes over 3 transfusion events preceding antibody detection. Eighteen alloantibodies were detected in 13 of 40 patients (32.5%), with an alloimmunization rate of 0.26 antibodies per 100 units transfused. Thirteen antibodies (72.2%) were directed against Rh (5 anti-D, 4 anti-C, 2 anti-E, 1 anti-e, 1 anti-V), despite donor phenotypes that confirmed lack of transfusion of D, C, or E antigens to patients lacking the corresponding antigen(s). Ten of 40 patients had an altered RH genotype, but the Rh antibodies were not associated with patients with variant RH. Black donors with a known high frequency of RH variants provided 63% of the units transfused in the 3 visits preceding unexplained anti-Rh detection. Rh alloimmunization not explained by the thalassemia patients' RH genotype or the donors' serologic phenotype suggests more precise matching is needed, and the role of donor RH genotypes on alloimmunization should be explored. Extending Rh D, C, and E matching to include c and e would result in better-matched units and further minimize Rh alloimmunization.
引用
- Waldis SJ, Uter S, Kavitsky D, et al. Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions. Blood Adv. 2021. PMID: 33560383. doi:10.1182/bloodadvances.2020003732
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。